Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review.

CONCLUSIONS: Azithromycin off-label use in pediatric ICUs does not appear to be associated with an increased risk of SAEs. Off-label use of fentanyl appears to be more frequently associated with respiratory depression when used off-label by both age and indication in pediatric ICUs. Prospective studies should be undertaken to assess the safety and efficacy of fentanyl in the pediatric population so that data can be added to the FDA labeling.
PMID: 30484072 [PubMed - as supplied by publisher]

Source: Paediatric Drugs - November 28, 2018 Category: Pediatrics Authors: Oshikoya KA, Wharton GT, Avant D, Van Driest SL, Fenn NE, Lardieri A, Doe E, Sood BG, Taketomo C, Lieu P, Yen L, McMahon AW Tags: Paediatr Drugs Source Type: research